Self-nanoemulsifying drug delivery system of cefpodoxime proxetil containing tocopherol polyethylene glycol succinate

References

• Alsenz J, Kansy M. (2007). High throughput solubility measurement in drug discovery and development. Adv Drug Deliv Rev, 59:546–567.
   PubMed Web of Science ®Google Scholar
• Prentis RA, Lis Y, Walker SR. (1988). Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985). Br J Clin Pharmacol, 25:387–396.
   PubMed Web of Science ®Google Scholar
• Vonderscher J, Meinzer A. (1994). Rationale for the development of Sandimmune Neoral. Transplant Proc, 26:2925–2927.
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P, Cloarec A, Arellano C, Houin G. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278:119–131.
   PubMed Web of Science ®Google Scholar
• Wandel C, Kim RB, Stein CM. (2003). “Inactive” excipients such as Cremophor can affect in vivo drug disposition. Clin Pharmacol Ther, 73:394–396.
   PubMed Web of Science ®Google Scholar
• Hauss DJ, Fogal SE, Ficorilli JV, Price CA, Roy T, Jayaraj AA et al. (1998). Lipid-based delivery systems for improving the bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164–169.
   PubMed Web of Science ®Google Scholar
• Rege B, Kao J, Polli J. (2002). Effect of nonionic surfactants on membrane transporters in Caco-2 cell monolayers.J Pharm Sci ,16:237–246.
   Web of Science ®Google Scholar
• Hauss D. (2007). Oral lipid-based formulations. Adv Drug Del Rev, 59:667–676.
   PubMed Web of Science ®Google Scholar
• Yongjun W, Jin S, Tianhong Z, Hongzhuo L, Fancui H, Zhonggui H. (2011). Enhanced oral bioavailability of tacrolimus in rats by self-microemulsifying drug delivery systems. Drug Dev Ind Pharmacy, 37(10):1225–1230.
   PubMed Web of Science ®Google Scholar
• Minghui S, Luqin S, Xuezhen Z, Zhaoze F, Yiming M, Rui Z, Xiangliang Y. (2011). Influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems. Drug Dev Ind Pharmacy, 37(8):986–994.
   PubMed Web of Science ®Google Scholar
• Xuemei W, Jianhua X, Xiuwang H, Caixia W. (2011). Self-microemulsifying drug delivery system improves curcumin dissolution and bioavailability. Drug Dev Ind Pharmacy, 37(1):15–23.
   PubMed Web of Science ®Google Scholar
• Zhongbin W, Dan G, Li D, Yue Z, Qiuxia Y, Jianming C. (2011). Preparation and evaluation of a self-emulsifying drug delivery system of etoposide–phospholipid complex. Drug Dev Ind Pharmacy, 37(1):103–112.
   PubMed Web of Science ®Google Scholar
• Dixit R, Nagarsenkar M. (2008). Formulation and in vivo evaluation of self-nanoemulsifying granules for oral delivery of a combination of ezetimibe and simvastatin. Drug Dev Ind Pharmacy, 34(12):1285–1296.
   PubMed Web of Science ®Google Scholar
• Myung J, Soo Y, Woo H, Jun S, Sung-Up C, Kyung T, Hyung-Kyoon C,et.al. (2011). Fujicalin®-based fast-dissolving self-emulsifying tablets. Drug Dev Ind Pharmacy, 37(11):1298–1305.
   PubMed Web of Science ®Google Scholar
• Todd WM. (1994). Cefpodoxime proxetil: a comprehensive review. Int J Antimicrob Agents, 4:37–62.
   PubMed Web of Science ®Google Scholar
• Chugh K, Agrawal S. (2003). Cefpodoxime: pharmacokinetics and therapeutic uses. Indian J Pediatr, 70:227–231.
   PubMedGoogle Scholar
• Vavia P, Patel A. (2007). Preparation and in vivo evaluation of self microemulsified drug delivery system containing fenofibrate. AAPS Pharm Sci Tech, 9(3): E344–E352.
   Google Scholar
• Hauss D, Fogal S, Ficorilli J, Price C. (1998). Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164–169.
   PubMed Web of Science ®Google Scholar
• Hauss DJ. (2007). Oral lipid-based formulations. Adv Drug Deliv Rev, 59:667–676.
   PubMed Web of Science ®Google Scholar
• Borhade V, Nair H, Hegde D. (2008). Design and evaluation of self-microemulsifying drug delivery system (SMEDDS) of tacrolimus. AAPS PharmSciTech, 9:13–21.
   PubMed Web of Science ®Google Scholar
• Martin A, Bustamante P, Chun AHC. (1993). Physical pharmacy: physical chemical principles in the pharmaceutical sciences. Philadelphia: Lea and Fabiger. 4th ed.
   Google Scholar
• Cappucino J, Sherman N. (1993). Microbiology–a laboratory manual. California: Addison Wesley.
   Google Scholar
• Gershanik T, Benita S. (2000). Self-dispersing formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179–188.
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. (2003). A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release, 86:33–48.
   PubMed Web of Science ®Google Scholar
• 1998). Vit.E TPGS, properties and applications. Eastman, USA:Publication EFC-226A.
   Google Scholar
• Shah N, Carvajal M et.al. (1994). Self-emulsifying drug delivery systems (SEDDS) with polyglycolized glycerides for improving in vitro dissolution and oral absorption of lipophilic drugs. Int J Pharm, 106:15–23.
   Web of Science ®Google Scholar
• Overbeek J. (1978). The First rideal lecture. Microemulsions, a field at the border between lyophobic and lyophilic colloids. Faraday Discuss Chem Soc, 65:7–19.
   Google Scholar
• Wang L, Dong J, Chen J, Eastoe J, Li X. (2009). Design and optimization of a new self-nanoemulsifying drug delivery system. J Colloid Interface Sci, 330:443–448.
   PubMed Web of Science ®Google Scholar
• Available at:http://www.antareshealthproducts.com/about_tpgs/properties.html (Accessed on 20.11.2011).
   Google Scholar
• Sharma M, Shiao S, Bansal V, Shah D. (1985). Effect of chain length compatibility on monolayers, foams and Macro- and Microemulsions.. In:Shah DO, ed., Macro- and microemulsions. Washington DC:American Chemistry Soceity, 87–103.
   Google Scholar
• Dai L, Li W, Hou X. (1997). Colloids surface. Physicochem Engg Aspects, 125:27–32.
   Web of Science ®Google Scholar
• Tharwat F. (2005). Applied surfactants: principles and applications. KgaA:Wiley-VCH Verlag, Gmbh & Co.
   Google Scholar
• Gershanik T, Benita S. (2000). Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. Eur J Pharm Biopharm, 50:179–188.
   PubMed Web of Science ®Google Scholar
• Shinoda K, Friberg S. (1986). Emulsions and solubilization. Chichester: John Wiley and Sons.
   Google Scholar
• Hamamura T, Kusai A, Nishimura K. (1995). Gel formation of cefpodoxime proxetil S.T.P Pharm Sci, 5: 324–331.
   Web of Science ®Google Scholar
• Hamamura T, Ohtani T, Kusai A, Nishimura K. (1995). Unusual dissolution behavior of cefpodoxime proxetil: effect of pH and ionic factors.S.T.P. Pharm Sci, 5:332–338.
   Web of Science ®Google Scholar
• Hamamura T, Terashima H, Ohtani T, et.al. (1995). Decrease in dissolution of cefpodoxime proxetil tablets by gel formation and its improvement. Yakuzaigaku,55:175–182.
   Google Scholar
• Crauste-Manciet S, Huneau J, Decroix M, Tome D, Chaumeil J. (1997). Cefpodoxime proxetil esterase activity in rabbit small intestine: role in the partial cefpodoxime absorption. Int J Pharm, 149:241–249.
   Web of Science ®Google Scholar
• Kakumanu VK, Arora V, Bansal AK. (2006). Investigation of factors responsible for low oral bioavailability of cefpodoxime proxetil. Int J Pharm, 317:155–160.
   PubMed Web of Science ®Google Scholar
• Cornaire G, Woodley J, Hermann P. (2004). Impact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivo. Int J Pharm, 278:4022–4031.
   Google Scholar
• Wandel C, Kim R, Stein M. (2003) Inactive excipients such as Cremophor can affect in vivo drug disposition. Clin Pharmacol Ther, 73(5):394–396.
   PubMed Web of Science ®Google Scholar
• Hauss D, Fogal S, Ficorilli J, Price C.(1998). Lipid-based delivery systems for improving bioavailability and lymphatic transport of a poorly water-soluble LTB4 inhibitor. J Pharm Sci, 87:164–169.
   PubMed Web of Science ®Google Scholar
• Rege BD, Kao JP, Polli JE. (2002). Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci, 16:237–246.
   PubMed Web of Science ®Google Scholar